Forbes April 24, 2024
William A. Haseltine

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses advances in brain-machine interfaces.

In 1999, I defined regenerative medicine as the collection of interventions that restore normal function to tissues and organs damaged by disease, injured by trauma, or worn by time. I include a full spectrum of chemical, gene, and protein-based medicines, cell-based therapies, and biomechanical interventions that achieve that goal.

In the mid-20th century, A.E. van Vogt wrote about the potentiality of telepathy in his work Slan. In his writing, mutations in the human germline resulted in a human derivative species capable of telepathy. Thanks to new technology, such advances in the human species may be on the brink of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices
UK sets out position on regulating AI as a medical device
Lab test overhaul: FDA to regulate LDTs as medical devices
QuidelOrtho names ex-Abbott exec Brian Blaser as CEO
Who's conducting layoffs in healthcare?
The medtech giants ASCs need to know

Share This Article